Background Catheter ablation of atrial fibrillation is typically performed with uninterrupted
anticoagulation with warfarin or interrupted non–vitamin K antagonist oral anticoagulant
therapy. Uninterrupted anticoagulation with a non–vitamin K antagonist oral anticoagulant,
such as dabigatran, may be safer; however, controlled data are lacking. We investigated the
safety of uninterrupted dabigatran versus warfarin in patients undergoing ablation of atrial
fibrillation. Methods In this randomized, open-label, multicenter, controlled trial with blinded …

… Uninterrupted rivaroxaban과 warfarin을 비교한 VENTURE-AF연구에서도 uninterrupted
rivaroxaban은 warfarin 대비 출혈 및 색전증의 위험이 높지 않는 것으로 되어 있다. … Meta-analysis
of efficacy and safety of new oral anticoagulants compared with uninterrupted vitamin K
antagonists in patients undergoing catheter ablation for atrial fibrillation. Am J Cardiol 2016;
117: 926-934. … uninterrupted vitamin K antagonists for catheter ablation in nonvalvular
atrial fibrillation. Eur Heart J 2015; 36: 1805-1811. …